Form EFFECT Galmed Pharmaceuticals
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 1, 2026 |
| Accession Number: | 0001493152-26-014239 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Genzeon Named UiPath 2026 Industry Impact Partner of the Year for Healthcare and Life Sciences
- Gateway Mortgage Recognized as One of National Mortgage Professional’s Most Loved Mortgage Employers
- Generational Group Advises Klein McCarthy Architects in its Sale to Wold Architects and Engineers, a Portfolio Company of Providus Capital Partners
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
